Seminar Series Schedule 2021-2022
Held virtually via zoom: Noon - 1 p.m. (CST)
Zoom Link
Meeting ID: 387 923 767
Passcode: 831342
| Date | Speaker | Title/Presentation |
| Aug. 23,2021 | Lucy A. Godley, M.D., Ph.D. Hospira Foundation Professor of Medicine and Human Genetics University of Chicago Medicine |
Germline predisposition for myelodysplasia and acute myelogenous leukemia View Presentation (BCM login required) |
| Sept. 20, 2021 |
Ann Mullally, M.D. |
Towards Rationally Designed Approaches to Treat Pre-clinical and Overt MPN View Presentation (BCM login required) |
| Oct. 4, 2021 |
Ola Landgren, M.D., Ph.D. |
Advances in therapy of relapsed/refractory myeloma View Presentation (BCM login required) |
| Oct. 18, 2021 |
Justin Lathia, Ph.D. |
Cancer stem cell-immune system interactions drive disease progression |
| Nov. 1, 2021 |
Robert Kridel, M.D., M.P.H., Ph.D. |
Off the shelf CAR T Cells in B Cell Malignancies |
| Nov. 15, 2021 |
Charlotte Graham, Ph.D. |
Off the shelf CAR T Cells in B Cell Malignancies |
| Nov. 29, 2021 |
Enrico Derenzini, M.D., Ph.D. |
Exploring the DNA damage response as a therapeutic target in DLBCL? |
| Dec. 13, 2021 |
Navdeep S. Chandel, Ph.D. |
Unraveling Cancer cell Metabolism |
| Dec. 27, 2021 | TBD | |
| Jan. 10, 2022 |
Eirini Papapetrou, M.D., Ph.D. |
Identifying novel AML targets |
| Jan. 24, 2022 |
Prof. Jesus M Hernandez M.D., Ph.D. |
MDS to AML transition |
| Feb. 7, 2022 |
Siddhartha Jaiswal, M.D., Ph.D. |
Clonogenic Mechanism Responsible for Hemopoietic Malignancy Transformation |
| Feb. 21, 2022 | TBD | |
| March 7, 2022 | Christopher Hourigan, M.D., D.Phil National Institutes of Health |
Advances in AML Meassurable residual disease |
